Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal

GABA release from interneurons in VTA, projections from the nucleus accumbens (NAc), and rostromedial tegmental nucleus (RMTg) was selectively activated in rat brain slices. The inhibition induced by μ-opioid agonists was pathway dependent. Morphine induced a 46% inhibition of IPSCs evoked from the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuron (Cambridge, Mass.) Mass.), 2014-06, Vol.82 (6), p.1346-1356
Hauptverfasser: Matsui, Aya, Jarvie, Brooke C., Robinson, Brooks G., Hentges, Shane T., Williams, John T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1356
container_issue 6
container_start_page 1346
container_title Neuron (Cambridge, Mass.)
container_volume 82
creator Matsui, Aya
Jarvie, Brooke C.
Robinson, Brooks G.
Hentges, Shane T.
Williams, John T.
description GABA release from interneurons in VTA, projections from the nucleus accumbens (NAc), and rostromedial tegmental nucleus (RMTg) was selectively activated in rat brain slices. The inhibition induced by μ-opioid agonists was pathway dependent. Morphine induced a 46% inhibition of IPSCs evoked from the RMTg, 18% from NAc, and IPSCs evoked from VTA interneurons were almost insensitive (11% inhibition). In vivo morphine treatment resulted in tolerance to the inhibition of RMTg, but not local interneurons or NAc, inputs. One common sign of opioid withdrawal is an increase in adenosine-dependent inhibition. IPSCs evoked from the NAc were potently inhibited by activation of presynaptic adenosine receptors, whereas IPSCs evoked from RMTg were not changed. Blockade of adenosine receptors selectively increased IPSCs evoked from the NAc during morphine withdrawal. Thus, the acute action of opioids, the development of tolerance, and the expression of withdrawal are mediated by separate GABA afferents to dopamine neurons. •GABA pathways to dopamine neurons are selectively sensitive to μ-opioid agonists•GABA pathways to dopamine neurons are selectively sensitive to adenosine agonists•Pathways that are most sensitive to opioids and adenosine are different•Morphine withdrawal is expressed selectively at terminals from nucleus accumbens Matsui et al. studied three opioid-sensitive GABA inputs to VTA dopamine neurons. The balance between initial sensitivity, development of tolerance, and expression of withdrawal were different for each pathway. Thus, different neuronal pathways regulate the three stages of opioid action.
doi_str_mv 10.1016/j.neuron.2014.04.030
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4072256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896627314003456</els_id><sourcerecordid>3339471991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c666t-bd599582587bf97ab6bafe58276cdbc666e3c516219f6099849e82cf325af33a3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEokvhHyBkiQuHZrGd2IkvSKEtBanQA0UcLccZU68SO7WTpT3zx3G6S_k4IFm2NPPMOzN-s-w5wWuCCX-9WTuYg3drikm5xukU-EG2IlhUeUmEeJitcC14zmlVHGRPYtzgBDJBHmcHtKxZhSlZZT8-w6iCmgCdNW8b1BgDAdwU0eTRiR_VYB2gT3eNIvoInV3QRs9392S9Q96gi9F628UjdAJb6P04JIUlful7CMppOELKdej0ZgwQ477oq52uuqC-q_5p9sioPsKz_XuYfXl3enn8Pj-_OPtw3JznmnM-5W3HhGA1ZXXVGlGplrfKQApUXHftwkChGeGUCMOxEHUpoKbaFJQpUxSqOMze7HTHuR2g02nKoHo5BjuocCu9svLvjLNX8pvfyhJXlDKeBF7tBYK_niFOcrBRQ98rB36OkjDGMKlEUSX05T_oxs_BpfUSlfKVKAVJVLmjdPAxBjD3wxAsF5flRu5clovLEqdT4FT24s9F7ot-2fp7U0jfubUQZNQWkhGdDaAn2Xn7_w4_AVDMu_k</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1537379491</pqid></control><display><type>article</type><title>Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Matsui, Aya ; Jarvie, Brooke C. ; Robinson, Brooks G. ; Hentges, Shane T. ; Williams, John T.</creator><creatorcontrib>Matsui, Aya ; Jarvie, Brooke C. ; Robinson, Brooks G. ; Hentges, Shane T. ; Williams, John T.</creatorcontrib><description>GABA release from interneurons in VTA, projections from the nucleus accumbens (NAc), and rostromedial tegmental nucleus (RMTg) was selectively activated in rat brain slices. The inhibition induced by μ-opioid agonists was pathway dependent. Morphine induced a 46% inhibition of IPSCs evoked from the RMTg, 18% from NAc, and IPSCs evoked from VTA interneurons were almost insensitive (11% inhibition). In vivo morphine treatment resulted in tolerance to the inhibition of RMTg, but not local interneurons or NAc, inputs. One common sign of opioid withdrawal is an increase in adenosine-dependent inhibition. IPSCs evoked from the NAc were potently inhibited by activation of presynaptic adenosine receptors, whereas IPSCs evoked from RMTg were not changed. Blockade of adenosine receptors selectively increased IPSCs evoked from the NAc during morphine withdrawal. Thus, the acute action of opioids, the development of tolerance, and the expression of withdrawal are mediated by separate GABA afferents to dopamine neurons. •GABA pathways to dopamine neurons are selectively sensitive to μ-opioid agonists•GABA pathways to dopamine neurons are selectively sensitive to adenosine agonists•Pathways that are most sensitive to opioids and adenosine are different•Morphine withdrawal is expressed selectively at terminals from nucleus accumbens Matsui et al. studied three opioid-sensitive GABA inputs to VTA dopamine neurons. The balance between initial sensitivity, development of tolerance, and expression of withdrawal were different for each pathway. Thus, different neuronal pathways regulate the three stages of opioid action.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2014.04.030</identifier><identifier>PMID: 24857021</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Afferent Pathways - drug effects ; Afferent Pathways - physiology ; Analgesics, Opioid - administration &amp; dosage ; Animals ; Brain ; Dopamine ; Dopaminergic Neurons - drug effects ; Dopaminergic Neurons - physiology ; Drug Tolerance - physiology ; Female ; gamma-Aminobutyric Acid - physiology ; Infusions, Intraventricular ; Male ; Neurons ; Organ Culture Techniques ; Parkinson's disease ; Rats ; Rats, Sprague-Dawley ; Substance Withdrawal Syndrome - metabolism</subject><ispartof>Neuron (Cambridge, Mass.), 2014-06, Vol.82 (6), p.1346-1356</ispartof><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Jun 18, 2014</rights><rights>2014 Elsevier Inc. All rights reserved. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c666t-bd599582587bf97ab6bafe58276cdbc666e3c516219f6099849e82cf325af33a3</citedby><cites>FETCH-LOGICAL-c666t-bd599582587bf97ab6bafe58276cdbc666e3c516219f6099849e82cf325af33a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0896627314003456$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24857021$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsui, Aya</creatorcontrib><creatorcontrib>Jarvie, Brooke C.</creatorcontrib><creatorcontrib>Robinson, Brooks G.</creatorcontrib><creatorcontrib>Hentges, Shane T.</creatorcontrib><creatorcontrib>Williams, John T.</creatorcontrib><title>Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal</title><title>Neuron (Cambridge, Mass.)</title><addtitle>Neuron</addtitle><description>GABA release from interneurons in VTA, projections from the nucleus accumbens (NAc), and rostromedial tegmental nucleus (RMTg) was selectively activated in rat brain slices. The inhibition induced by μ-opioid agonists was pathway dependent. Morphine induced a 46% inhibition of IPSCs evoked from the RMTg, 18% from NAc, and IPSCs evoked from VTA interneurons were almost insensitive (11% inhibition). In vivo morphine treatment resulted in tolerance to the inhibition of RMTg, but not local interneurons or NAc, inputs. One common sign of opioid withdrawal is an increase in adenosine-dependent inhibition. IPSCs evoked from the NAc were potently inhibited by activation of presynaptic adenosine receptors, whereas IPSCs evoked from RMTg were not changed. Blockade of adenosine receptors selectively increased IPSCs evoked from the NAc during morphine withdrawal. Thus, the acute action of opioids, the development of tolerance, and the expression of withdrawal are mediated by separate GABA afferents to dopamine neurons. •GABA pathways to dopamine neurons are selectively sensitive to μ-opioid agonists•GABA pathways to dopamine neurons are selectively sensitive to adenosine agonists•Pathways that are most sensitive to opioids and adenosine are different•Morphine withdrawal is expressed selectively at terminals from nucleus accumbens Matsui et al. studied three opioid-sensitive GABA inputs to VTA dopamine neurons. The balance between initial sensitivity, development of tolerance, and expression of withdrawal were different for each pathway. Thus, different neuronal pathways regulate the three stages of opioid action.</description><subject>Afferent Pathways - drug effects</subject><subject>Afferent Pathways - physiology</subject><subject>Analgesics, Opioid - administration &amp; dosage</subject><subject>Animals</subject><subject>Brain</subject><subject>Dopamine</subject><subject>Dopaminergic Neurons - drug effects</subject><subject>Dopaminergic Neurons - physiology</subject><subject>Drug Tolerance - physiology</subject><subject>Female</subject><subject>gamma-Aminobutyric Acid - physiology</subject><subject>Infusions, Intraventricular</subject><subject>Male</subject><subject>Neurons</subject><subject>Organ Culture Techniques</subject><subject>Parkinson's disease</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Substance Withdrawal Syndrome - metabolism</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhiMEokvhHyBkiQuHZrGd2IkvSKEtBanQA0UcLccZU68SO7WTpT3zx3G6S_k4IFm2NPPMOzN-s-w5wWuCCX-9WTuYg3drikm5xukU-EG2IlhUeUmEeJitcC14zmlVHGRPYtzgBDJBHmcHtKxZhSlZZT8-w6iCmgCdNW8b1BgDAdwU0eTRiR_VYB2gT3eNIvoInV3QRs9392S9Q96gi9F628UjdAJb6P04JIUlful7CMppOELKdej0ZgwQ477oq52uuqC-q_5p9sioPsKz_XuYfXl3enn8Pj-_OPtw3JznmnM-5W3HhGA1ZXXVGlGplrfKQApUXHftwkChGeGUCMOxEHUpoKbaFJQpUxSqOMze7HTHuR2g02nKoHo5BjuocCu9svLvjLNX8pvfyhJXlDKeBF7tBYK_niFOcrBRQ98rB36OkjDGMKlEUSX05T_oxs_BpfUSlfKVKAVJVLmjdPAxBjD3wxAsF5flRu5clovLEqdT4FT24s9F7ot-2fp7U0jfubUQZNQWkhGdDaAn2Xn7_w4_AVDMu_k</recordid><startdate>20140618</startdate><enddate>20140618</enddate><creator>Matsui, Aya</creator><creator>Jarvie, Brooke C.</creator><creator>Robinson, Brooks G.</creator><creator>Hentges, Shane T.</creator><creator>Williams, John T.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20140618</creationdate><title>Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal</title><author>Matsui, Aya ; Jarvie, Brooke C. ; Robinson, Brooks G. ; Hentges, Shane T. ; Williams, John T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c666t-bd599582587bf97ab6bafe58276cdbc666e3c516219f6099849e82cf325af33a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Afferent Pathways - drug effects</topic><topic>Afferent Pathways - physiology</topic><topic>Analgesics, Opioid - administration &amp; dosage</topic><topic>Animals</topic><topic>Brain</topic><topic>Dopamine</topic><topic>Dopaminergic Neurons - drug effects</topic><topic>Dopaminergic Neurons - physiology</topic><topic>Drug Tolerance - physiology</topic><topic>Female</topic><topic>gamma-Aminobutyric Acid - physiology</topic><topic>Infusions, Intraventricular</topic><topic>Male</topic><topic>Neurons</topic><topic>Organ Culture Techniques</topic><topic>Parkinson's disease</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Substance Withdrawal Syndrome - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsui, Aya</creatorcontrib><creatorcontrib>Jarvie, Brooke C.</creatorcontrib><creatorcontrib>Robinson, Brooks G.</creatorcontrib><creatorcontrib>Hentges, Shane T.</creatorcontrib><creatorcontrib>Williams, John T.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsui, Aya</au><au>Jarvie, Brooke C.</au><au>Robinson, Brooks G.</au><au>Hentges, Shane T.</au><au>Williams, John T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><addtitle>Neuron</addtitle><date>2014-06-18</date><risdate>2014</risdate><volume>82</volume><issue>6</issue><spage>1346</spage><epage>1356</epage><pages>1346-1356</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>GABA release from interneurons in VTA, projections from the nucleus accumbens (NAc), and rostromedial tegmental nucleus (RMTg) was selectively activated in rat brain slices. The inhibition induced by μ-opioid agonists was pathway dependent. Morphine induced a 46% inhibition of IPSCs evoked from the RMTg, 18% from NAc, and IPSCs evoked from VTA interneurons were almost insensitive (11% inhibition). In vivo morphine treatment resulted in tolerance to the inhibition of RMTg, but not local interneurons or NAc, inputs. One common sign of opioid withdrawal is an increase in adenosine-dependent inhibition. IPSCs evoked from the NAc were potently inhibited by activation of presynaptic adenosine receptors, whereas IPSCs evoked from RMTg were not changed. Blockade of adenosine receptors selectively increased IPSCs evoked from the NAc during morphine withdrawal. Thus, the acute action of opioids, the development of tolerance, and the expression of withdrawal are mediated by separate GABA afferents to dopamine neurons. •GABA pathways to dopamine neurons are selectively sensitive to μ-opioid agonists•GABA pathways to dopamine neurons are selectively sensitive to adenosine agonists•Pathways that are most sensitive to opioids and adenosine are different•Morphine withdrawal is expressed selectively at terminals from nucleus accumbens Matsui et al. studied three opioid-sensitive GABA inputs to VTA dopamine neurons. The balance between initial sensitivity, development of tolerance, and expression of withdrawal were different for each pathway. Thus, different neuronal pathways regulate the three stages of opioid action.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24857021</pmid><doi>10.1016/j.neuron.2014.04.030</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0896-6273
ispartof Neuron (Cambridge, Mass.), 2014-06, Vol.82 (6), p.1346-1356
issn 0896-6273
1097-4199
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4072256
source MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Afferent Pathways - drug effects
Afferent Pathways - physiology
Analgesics, Opioid - administration & dosage
Animals
Brain
Dopamine
Dopaminergic Neurons - drug effects
Dopaminergic Neurons - physiology
Drug Tolerance - physiology
Female
gamma-Aminobutyric Acid - physiology
Infusions, Intraventricular
Male
Neurons
Organ Culture Techniques
Parkinson's disease
Rats
Rats, Sprague-Dawley
Substance Withdrawal Syndrome - metabolism
title Separate GABA Afferents to Dopamine Neurons Mediate Acute Action of Opioids, Development of Tolerance, and Expression of Withdrawal
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T15%3A04%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Separate%20GABA%20Afferents%20to%20Dopamine%20Neurons%20Mediate%20Acute%20Action%20of%20Opioids,%20Development%20of%20Tolerance,%20and%20Expression%20of%20Withdrawal&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Matsui,%20Aya&rft.date=2014-06-18&rft.volume=82&rft.issue=6&rft.spage=1346&rft.epage=1356&rft.pages=1346-1356&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2014.04.030&rft_dat=%3Cproquest_pubme%3E3339471991%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1537379491&rft_id=info:pmid/24857021&rft_els_id=S0896627314003456&rfr_iscdi=true